Macarulla, T., Cervantes, A., Tabernero, J., Roselló, S., Van Cutsem, E., Tejpar, S., . . . Ciardiello, F. (2015). Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer. Br J Cancer.
Chicago Stili AlıntıMacarulla, T., et al. "Phase I Study of FOLFIRI Plus Pimasertib As Second-line Treatment for KRAS-mutated Metastatic Colorectal Cancer." Br J Cancer 2015.
MLA AlıntıMacarulla, T., et al. "Phase I Study of FOLFIRI Plus Pimasertib As Second-line Treatment for KRAS-mutated Metastatic Colorectal Cancer." Br J Cancer 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..